BDNF Plasma Levels and BDNF Exon IV Promoter Methylation as Predictors for Antidepressant Treatment Response

Major problems of current antidepressant pharmacotherapy are insufficient response rates and difficulties in response prediction. We recently provided preliminary evidence in a small study that patients with major depressive disorder (MDD) with a hypomethylation of the CpG-87 site of the promoter IV...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Front Psychiatry
Autori principali: Lieb, Klaus, Dreimüller, Nadine, Wagner, Stefanie, Schlicht, Konrad, Falter, Tanja, Neyazi, Alexandra, Müller-Engling, Linda, Bleich, Stefan, Tadić, André, Frieling, Helge
Natura: Artigo
Lingua:Inglês
Pubblicazione: Frontiers Media S.A. 2018
Soggetti:
Psychiatry
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6232909/
https://ncbi.nlm.nih.gov/pubmed/30459647
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fpsyt.2018.00511
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi